Three units for demonstration within Verizon Innovation Labs VANCOUVER, BC / ACCESS Newswire / November 25, 2025 / UniDoc ...
PSA is a validated FDA-recognized clinical endpoint in assessing prostate cancer treatment response; Telomir-1 lowered PSA levels in a dose-related manner. MIAMI, FLORIDA / ACCESS Newswire / November ...
VSee Health's iDoc Division Powers Ahead: Delivering on Major Contracts and Igniting Revenue Growth!
SAN JOSE, CALIFORNIA / ACCESS Newswire / November 25, 2025 / VSee Health, Inc. (NASDAQ:VSEE), a leader in innovative telemedicine solutions, today announced exciting progress in implementing and ...
Electronic Caregiver's 24/7 virtual caregiving platform steps forward just as payers move away from low-engagement, device-only monitoring. LAS CRUCES, NM / ACCESS Newswire / November 25, 2025 / ...
For immediate release 24 NovemberAngelini Pharma UK-I Limited has breached the ABPI Code of Practice for the Pharmaceutical Industry ...
GS1 brings trusted medical product information to smartphones through collaboration with GoogleLaunch of smartphone camera scanning of GS1 DataMatrix barcodes marks a global breakthrough for patient ...
BioMed X Announces New Neuroscience Research Collaboration in the USA The new project in collaboration with AbbVie aims to unravel the mechanisms of anhedonia and to identify novel therapeutic ...
New partnership to advance cancer and metabolic disease research while training Scotland’s next generation of drug discovery scientists [Glasgow, UK – 25 November 2025] – BioAscent, a leading provider ...
LUND, SE / ACCESS Newswire / November 25, 2025 / Alligator Bioscience (STO:ATORX) - Today, on 25 November 2025, an extraordinary general meeting was held in Alligator Bioscience AB. A summary of the ...
Approval based on phase 3 studies showing Dupixent significantly reduced itch and hives at 24 weeks compared to placeboIn the EU, there are approximately 270,000 adults and adolescents aged 12 years ...
With planned investment of over £800m, the Cluster brings together Barts Health NHS Trust and private investors to unite clinical excellence and commercial innovation.Science Minister Lord Vallance ...
Adalyon Appoints Ulrik Zeuthen as CEO to Drive Next Phase of Growth in AI-driven Speech-based Biomarkers and Behavioural Analytics for Optimising Clinical Trials Espoo, Finland – 25 November 2025 – ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results